While current guidelines emphasize CD4+ count and viral suppression, persistent elevation of PD-1/PD-L1—even in virologically suppressed individuals—may signal residual immune dysfunction and increased risk for comorbidities. The gene discussed is PDCD1; the disease is immune system disorder.